Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - TOTAL CURRENT LIABILITIES
Total Current Liabilities RARE - Ultragenyx Pharmaceutical Inc.
344 M
LAST VALUE
14.78%
2 YEAR CAGR
27.21%
5 YEAR CAGR
39.29%
10 YEAR CAGR